Tradolan Retard

Tradolan Retard contains tramadol hydrochloride, an extended-release oral opioid analgesic for extended pain relief. Suitable for managing moderate to severe chronic pain when continuous relief is needed. Designed for prolonged action to reduce dosing frequency.

Tramadol hydrochloride, the active ingredient in Tradolan Retard, is commonly used to treat moderate to severe pain that requires around-the-clock management. It is often prescribed for chronic conditions such as osteoarthritis, back pain, or post-surgical discomfort where extended pain control is beneficial. This medication belongs to the opioid class and works by altering the body’s perception of pain.

Tradolan Retard provides gradual and sustained pain relief over an extended period, helping maintain consistent comfort throughout the day. Patients may experience a reduction in pain intensity and improved ability to perform daily activities. The extended-release formulation aims to minimize peaks and troughs in pain relief compared to immediate-release options.

Tradolan Retard should be stored securely away from children and pets to prevent accidental ingestion. It is important to follow the prescribed dosing schedule and not crush or chew the tablets, as this can release too much medication at once. Patients should avoid alcohol and consult a healthcare provider if they have a history of substance use or respiratory conditions.

Concurrent use of alcohol or sedatives with Tradolan Retard may increase the risk of drowsiness or respiratory depression. Medications that affect liver enzymes, such as certain antidepressants or antifungals, can alter tramadol metabolism. Patients taking other central nervous system depressants should use caution and discuss potential risks with a healthcare provider.